article thumbnail

OPDP Comes out Swinging With A Warning Letter on Unsubstantiated Efficacy

FDA Law Blog

Breztri was approved just over 3 years ago in July 2020 for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The indication includes a limitation of use that Breztri is not indicated for the relief of acute bronchospasm or for the treatment of asthma.

article thumbnail

Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model

BMJ

We sought to analyse how prescribing trends have changed over time, utilising a dataset containing all prescriptions signed and dispensed in the UK by primary care facilities from January 2014 to November 2020.